Cargando…

Odor identification as a biomarker of preclinical AD in older adults at risk

OBJECTIVE: To assess odor identification (OI) as an indicator of presymptomatic Alzheimer disease (AD) pathogenesis in cognitively normal aging individuals at increased risk of AD dementia. METHODS: In 274 members of the PREVENT-AD cohort of healthy aging persons with a parental or multiple-sibling...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lafaille-Magnan, Marie-Elyse, Poirier, Judes, Etienne, Pierre, Tremblay-Mercier, Jennifer, Frenette, Joanne, Rosa-Neto, Pedro, Breitner, John C.S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574678/ https://www.ncbi.nlm.nih.gov/pubmed/28659431 http://dx.doi.org/10.1212/WNL.0000000000004159

Ejemplares similares

INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
por: Meyer, Pierre-François, et al.
Publicado: (2019)

Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer’s disease
por: Tremblay-Mercier, Jennifer, et al.
Publicado: (2021)

APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer’s Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset
por: Rabipour, Sheida, et al.
Publicado: (2020)

Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer’s Disease
por: Tuwaig, Miranda, et al.
Publicado: (2017)

No apparent effect of naproxen on CSF markers of innate immune activation
por: Meyer, Pierre‐François, et al.
Publicado: (2019)

Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer’s Disease Pathogenesis
por: Meyer, Pierre-François, et al.
Publicado: (2018)

How can we really improve screening methods for AD prevention trials?
por: Breitner, John C.S.
Publicado: (2016)

Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease
por: Picard, Cynthia, et al.
Publicado: (2021)

Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer’s disease
por: Pichet Binette, Alexa, et al.
Publicado: (2021)

Brain properties predict proximity to symptom onset in sporadic Alzheimer’s disease
por: Vogel, Jacob W, et al.
Publicado: (2018)

Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer’s Disease
por: Konishi, Kyoko, et al.
Publicado: (2018)

Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study
por: Henderson, Samuel T, et al.
Publicado: (2011)

Motor system alterations in retired former athletes: the role of aging and concussion history
por: De Beaumont, Louis, et al.
Publicado: (2013)

Could Lipoprotein Lipase Play a Role in Alzheimer's Disease?
por: Blain, Jean-Francois, et al.
Publicado: (2004)

BDNF Val(66)Met Polymorphism Influences Visuomotor Associative Learning and the Sensitivity to Action Observation
por: Taschereau-Dumouchel, Vincent, et al.
Publicado: (2016)

Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer’s disease
por: Orban, Pierre, et al.
Publicado: (2015)

The EMIF-AD PreclinAD study: study design and baseline cohort overview
por: Konijnenberg, Elles, et al.
Publicado: (2018)

Disease progression modelling from preclinical Alzheimer’s disease (AD) to AD dementia
por: Cho, Soo Hyun, et al.
Publicado: (2021)

Impaired Odor Identification of Culturally Familiar Odorants Associated with Dementia in South Korean Older Adults
por: Kim, Sun Mi, et al.
Publicado: (2020)

Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression
por: Liebsch, Filip, et al.
Publicado: (2019)

Odor mental imagery in non-experts in odors: a paradox?
por: Royet, Jean-Pierre, et al.
Publicado: (2013)

Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer’s disease: A genetic and proteomic multi-cohort study
por: Picard, Cynthia, et al.
Publicado: (2019)

Social isolation is linked to classical risk factors of Alzheimer’s disease-related dementias
por: Shafighi, Kimia, et al.
Publicado: (2023)

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
por: Ng, Kok Pin, et al.
Publicado: (2021)

Polymorphism of the 5-HT(2A) Receptor Gene: Association with Stress-Related Indices in Healthy Middle-Aged Adults
por: Fiocco, Alexandra J., et al.
Publicado: (2007)

Cortical thickness in relation to clinical symptom onset in preclinical AD
por: Pettigrew, Corinne, et al.
Publicado: (2016)

Selective familiarity deficits in otherwise cognitively intact aging individuals with genetic risk for Alzheimer's disease
por: Schoemaker, Dorothee, et al.
Publicado: (2015)

Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer’s Disease Spectrum
por: Nilsson, Nathalie I. V., et al.
Publicado: (2021)

Dynamic Amyloid and Metabolic Signatures of Delayed Recall Performance within the Clinical Spectrum of Alzheimer’s Disease
por: Tedeschi Dauar, Marina, et al.
Publicado: (2023)

Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities
por: Parent, Maxime J., et al.
Publicado: (2017)

Bilateral and unilateral odor processing and odor perception
por: Dalal, Tal, et al.
Publicado: (2020)

Altered Episodic Memory in Introverted Young Adults Carrying the BDNF(Met) Allele
por: Bombardier, Andreanne, et al.
Publicado: (2016)

Influence of the Chemical Structure on Odor Qualities and Odor Thresholds of Halogenated Guaiacol-Derived Odorants
por: Juhlke, Florian, et al.
Publicado: (2017)

Cognitive Phenotypes, Brain Morphometry and the Detection of Cognitive Decline in Preclinical AD
por: Jacobson, Mark W., et al.
Publicado: (2009)

CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem
por: Benedet, Andréa L., et al.
Publicado: (2018)

Comparative Effects of Repetitive Odor Identification and Odor Memory Tasks on Olfactory Engagement in Older Populations – A Pilot fMRI Study
por: Rai, Narayan, et al.
Publicado: (2021)

Hierarchical Elemental Odor Coding for Fine Discrimination Between Enantiomer Odors or Cancer-Characteristic Odors
por: Sato, Takaaki, et al.
Publicado: (2022)

OlfactionBase: a repository to explore odors, odorants, olfactory receptors and odorant–receptor interactions
por: Sharma, Anju, et al.
Publicado: (2021)

Antroquinonol administration in animal preclinical studies for Alzheimer's disease (AD): A new avenue for modifying progression of AD pathophysiology
por: Francesca, Fernandez, et al.
Publicado: (2022)

Familiarity deficits in cognitively normal aging individuals with APOE ε4: A follow-up investigation of medial temporal lobe structural correlates
por: Schoemaker, Dorothee, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h44tsld6nq5lhh9fpfd1oics1e